Vertex Pharmaceuticals Incorporated Total Non Current Liabilities 2011-2026 | VRTX

Annual Total Non Current Liabilities Vertex Pharmaceuticals Incorporated

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	898 M	690 M	696 M	766 M	899 M	870 M	565 M	1.13 B	846 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.13 B	565 M	818 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
Apellis Pharmaceuticals APLS	289 M	$ 20.32	-1.86 %	$ 2.56 B	USA
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Aptorum Group Limited APM	2.21 M	$ 0.82	-2.7 %	$ 4.47 M	China
Axsome Therapeutics AXSM	48.9 M	$ 165.39	-0.6 %	$ 8.23 B	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
AbCellera Biologics ABCL	326 M	$ 3.65	-4.58 %	$ 1.09 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Corvus Pharmaceuticals CRVS	2.31 M	$ 17.24	-3.63 %	$ 828 M	USA
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Capricor Therapeutics CAPR	4.86 M	$ 25.62	-4.62 %	$ 686 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Codexis CDXS	28.2 M	$ 0.99	-2.59 %	$ 72.7 M	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	264 M	$ 3.18	-4.94 %	$ 1.14 M	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	157 M	$ 28.47	-2.5 %	$ 1.65 B	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Завод ДИОД DIOD	89.5 M	-	-	-	Russia
Фармсинтез LIFE	13.2 M	-	-	-	Russia
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
Cellectis S.A. CLLS	109 M	$ 3.64	-4.21 %	$ 116 M	France
Alector ALEC	165 M	$ 2.13	-3.39 %	$ 219 M	USA
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	4.59 M	-	10.36 %	$ 9.8 M	USA
Altimmune ALT	5.33 M	$ 4.15	-0.24 %	$ 295 M	USA
Teligent, Inc. TLGT	142 M	-	-13.85 %	$ 16.1 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Viela Bio, Inc. VIE	1.38 M	-	-	$ 2.91 B	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Catalyst Pharmaceuticals CPRX	648 K	$ 24.06	0.75 %	$ 2.94 B	USA
Amarin Corporation plc AMRN	31.7 M	$ 13.95	0.14 %	$ 5.79 B	Irlanda
AbbVie ABBV	81.7 B	$ 231.93	-0.98 %	$ 410 B	USA
Blueprint Medicines Corporation BPMC	137 M	-	-	$ 8.14 B	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA